Market News

McCarthy Stone Plc (LON:MCS) Stock Rating Reiterated by Deutsche Bank; The GBX 219.00 Target Indicates 32.93% Potential; Staar Surgical Company (STAA) SI Decreased By 0.1%

The broker have set PT of GBX 219.00 on McCarthy Stone Plc (LON:MCS) shares. This is 32.93% from the last close price. In analysts report released on Thursday, 30 November, Deutsche Bank kept their Buy rating on shares of MCS.

Staar Surgical Company (NASDAQ:STAA) had a decrease of 0.1% in short interest. STAA’s SI was 1.52M shares in November as released by FINRA. Its down 0.1% from 1.52M shares previously. With 61,600 avg volume, 25 days are for Staar Surgical Company (NASDAQ:STAA)’s short sellers to cover STAA’s short positions. The SI to Staar Surgical Company’s float is 5.89%. The stock increased 4.19% or $0.7 during the last trading session, reaching $17.4. About 267,020 shares traded or 105.38% up from the average. STAAR Surgical Company (NASDAQ:STAA) has risen 79.17% since November 30, 2016 and is uptrending. It has outperformed by 62.47% the S&P500.

McCarthy & Stone plc, together with its subsidiaries, operates as a retirement house builder in the United Kingdom. The company has market cap of 881.22 million GBP. The firm builds, sells, and manages retirement developments. It has a 12.71 P/E ratio. It offers retirement living developments that provide owner-occupied apartments for those aged 60 and over; assisted living developments, which are designed for clients aged 70 and offers a retirement apartment with management services, domestic assistance, personal care, and additional support; and Ortus Homes for clients aged 55 and over.

Analysts await McCarthy & Stone plc (LON:MCS.L) to report earnings on February, 22. They expect $0.43 EPS, up 38.71% or $0.12 from last year’s $0.31 per share. MCS’s profit will be $2.31 million for 95.35 P/E if the $0.43 EPS becomes a reality. After $0.39 actual EPS reported by McCarthy & Stone plc for the previous quarter, Wall Street now forecasts 10.26% EPS growth.

The stock increased 0.37% or GBX 0.6 during the last trading session, reaching GBX 164. About 285,905 shares traded. McCarthy & Stone plc (LON:MCS) has 0.00% since November 30, 2016 and is . It has underperformed by 16.70% the S&P500.

Among 9 analysts covering Mccarthy Stone Plc (LON:MCS), 6 have Buy rating, 2 Sell and 1 Hold. Therefore 67% are positive. Mccarthy Stone Plc has GBX 330 highest and GBX 150 lowest target. GBX 198.78’s average target is 21.21% above currents GBX 164 stock price. Mccarthy Stone Plc had 90 analyst reports since December 17, 2015 according to SRatingsIntel. The company was maintained on Tuesday, November 1 by Deutsche Bank. The firm has “Sell” rating given on Wednesday, October 12 by UBS. The company was maintained on Wednesday, April 26 by Peel Hunt. The stock has “Buy” rating by HSBC on Wednesday, December 7. On Thursday, July 13 the stock rating was downgraded by Barclays Capital to “Underweight”. On Tuesday, November 15 the stock rating was maintained by Peel Hunt with “Buy”. The stock of McCarthy & Stone plc (LON:MCS.L) has “Buy” rating given on Monday, February 8 by Peel Hunt. The stock of McCarthy & Stone plc (LON:MCS.L) has “Buy” rating given on Wednesday, July 5 by Peel Hunt. UBS maintained it with “Sell” rating and GBX 150 target in Tuesday, September 20 report. The stock has “Buy” rating by Deutsche Bank on Monday, November 6.

Among 2 analysts covering STAAR Surgical (NASDAQ:STAA), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. STAAR Surgical had 11 analyst reports since January 29, 2016 according to SRatingsIntel. Canaccord Genuity maintained it with “Hold” rating and $900 target in Monday, July 10 report. The stock of STAAR Surgical Company (NASDAQ:STAA) earned “Buy” rating by Canaccord Genuity on Friday, November 17. The rating was maintained by Canaccord Genuity on Thursday, August 3 with “Hold”. The stock has “Buy” rating by Canaccord Genuity on Sunday, October 8. Benchmark initiated it with “Hold” rating and $7 target in Friday, January 29 report. Canaccord Genuity maintained the stock with “Buy” rating in Wednesday, November 8 report. The firm has “Buy” rating given on Monday, September 25 by Canaccord Genuity. The firm has “Hold” rating given on Monday, September 4 by Canaccord Genuity. Benchmark maintained the shares of STAA in report on Monday, November 20 with “Buy” rating.

STAAR Surgical Company, together with its subsidiaries, designs, develops, makes, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company has market cap of $716.26 million. The firm provides Visian implantable collamer lenses to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It currently has negative earnings. It also offers minimally invasive intraocular lenses (IOLs), including foldable IOLs for use in minimally invasive cataract surgical procedures; aspheric IOLs that produce a clearer image than traditional spherical lenses; and nanoFLEX IOL, a single piece collamer aspheric optic, as well as preloaded injectors for use in cataract surgery.

Investors sentiment increased to 1.77 in Q2 2017. Its up 0.60, from 1.17 in 2017Q1. It increased, as 3 investors sold STAAR Surgical Company shares while 19 reduced holdings. 14 funds opened positions while 25 raised stakes. 31.04 million shares or 1.57% more from 30.56 million shares in 2017Q1 were reported. Alliancebernstein Limited Partnership invested in 54,300 shares or 0% of the stock. Vanguard Grp reported 1.28M shares. Great West Life Assurance Can accumulated 5,357 shares. Tiverton Asset Mngmt, Delaware-based fund reported 324,821 shares. D E Shaw Co Incorporated accumulated 0% or 26,793 shares. Employees Retirement Association Of Colorado reported 19,521 shares. Barclays Public Ltd Company, United Kingdom-based fund reported 131 shares. Archon Capital Ltd owns 4,800 shares. Tower Capital Ltd (Trc) accumulated 0% or 32 shares. Broadwood Cap Inc invested in 10.86 million shares. Pdts Prtnrs Ltd Limited Liability Company holds 0.01% or 25,700 shares in its portfolio. Art Limited Com invested in 0.01% or 12,809 shares. California-based California State Teachers Retirement Systems has invested 0% in STAAR Surgical Company (NASDAQ:STAA). Stephens Inc Ar invested in 12,238 shares. Wells Fargo Mn holds 52,912 shares or 0% of its portfolio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *